|
Volumn 21, Issue 3, 2014, Pages 155-163
|
Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
BIOMATERIAL;
DELAYED RELEASE FORMULATION;
DRUG CARRIER;
IMIDAZOLE DERIVATIVE;
METHOTREXATE;
NANOCOMPOSITE;
POLYMETHACRYLIC ACID;
POLYMETHACRYLIC ACID DERIVATIVE;
SILICON DIOXIDE;
CELL PROLIFERATION;
CELL SURVIVAL;
CHEMISTRY;
DELAYED RELEASE FORMULATION;
DOSE RESPONSE;
DRUG EFFECTS;
HUMAN;
INFRARED SPECTROSCOPY;
MCF 7 CELL LINE;
MEDICINAL CHEMISTRY;
NANOTECHNOLOGY;
PH;
PHARMACEUTICS;
PROCEDURES;
PROTON NUCLEAR MAGNETIC RESONANCE;
SCANNING ELECTRON MICROSCOPY;
SOLUBILITY;
SYNTHESIS;
THERMOGRAVIMETRY;
TIME;
TOXICITY;
ANTIMETABOLITES, ANTINEOPLASTIC;
BIOCOMPATIBLE MATERIALS;
CELL PROLIFERATION;
CELL SURVIVAL;
CHEMISTRY, PHARMACEUTICAL;
DELAYED-ACTION PREPARATIONS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG CARRIERS;
HUMANS;
HYDROGEN-ION CONCENTRATION;
IMIDAZOLES;
MCF-7 CELLS;
METHOTREXATE;
MICROSCOPY, ELECTRON, SCANNING;
NANOCOMPOSITES;
NANOTECHNOLOGY;
POLYMETHACRYLIC ACIDS;
PROTON MAGNETIC RESONANCE SPECTROSCOPY;
SILICON DIOXIDE;
SOLUBILITY;
SPECTROSCOPY, FOURIER TRANSFORM INFRARED;
TECHNOLOGY, PHARMACEUTICAL;
THERMOGRAVIMETRY;
TIME FACTORS;
|
EID: 84921940147
PISSN: None
EISSN: 15210464
Source Type: Journal
DOI: 10.3109/10717544.2013.838714 Document Type: Article |
Times cited : (53)
|
References (0)
|